Should we reduce dosing frequency in Biologic responders: Pros and Cons? .ical 09-11, 17:30–18:00 (Europe/Istanbul), Rhinology 1 (ICC - B2 level BEYAZIT) <p>Should we reduce dosing frequency in Biologic responders: Pros and Cons?</p> <p></p> Speaker Speaker Valerie Hox David Liu Valerie Hox <p></p> This speaker also appears in: BIOLOGICS IN ALLERGIC RHINITIS , WHAT CHANGED IN TREATMENT David Liu <p></p> This speaker also appears in: CRS outcomes and disease control – Are we doing well? Quality of life after skull base surgery: Are we doing well? Intranasal Benign Tumours The Principles of FESS: A Step-by-Step Guide for the Novice
